Many serious or potentially fatal adverse reactions associated with new, targeted anti-cancer agents are not reported in the original published research on the drug, and they are not known to oncologists until years later when drug labels are updated, including boxed warnings, according to research published online in the Journal of Clinical Oncology, HealthDay News reported.

Researchers conducted a review of 12 targeted anti-cancer agents with updated drug labels because of safety concerns and 36 corresponding randomized controlled trials (RCTs) referenced in the updated labels.......click for more

Source Web Page: Modern Medicine